KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aurinia Pharmaceuticals (AUPH) Inventory (2020 - 2025)

Historic Inventory for Aurinia Pharmaceuticals (AUPH) over the last 6 years, with Q3 2025 value amounting to $44.8 million.

  • Aurinia Pharmaceuticals' Inventory rose 1570.23% to $44.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $44.8 million, marking a year-over-year increase of 1570.23%. This contributed to the annual value of $39.2 million for FY2024, which is 120.14% down from last year.
  • Latest data reveals that Aurinia Pharmaceuticals reported Inventory of $44.8 million as of Q3 2025, which was up 1570.23% from $46.5 million recorded in Q2 2025.
  • Aurinia Pharmaceuticals' 5-year Inventory high stood at $46.5 million for Q2 2025, and its period low was $15.9 million during Q1 2021.
  • For the 5-year period, Aurinia Pharmaceuticals' Inventory averaged around $31.9 million, with its median value being $32.8 million (2023).
  • Its Inventory has fluctuated over the past 5 years, first skyrocketed by 18552.61% in 2021, then plummeted by 120.14% in 2024.
  • Aurinia Pharmaceuticals' Inventory (Quarter) stood at $19.3 million in 2021, then increased by 28.08% to $24.8 million in 2022, then surged by 60.41% to $39.7 million in 2023, then decreased by 1.2% to $39.2 million in 2024, then grew by 14.19% to $44.8 million in 2025.
  • Its Inventory was $44.8 million in Q3 2025, compared to $46.5 million in Q2 2025 and $46.2 million in Q1 2025.